$50.58
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Akero Therapeutics (AKRO) Forecast
NewsEarningsAkero Therapeutics (AKRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestAkero Therapeutics (NASDAQ:AKRO) Stock Quotes, Forecast and News Summary
Akero Therapeutics Stock (NASDAQ: AKRO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akero Therapeutics (AKRO) stock?
You can purchase shares of Akero Therapeutics (NASDAQ:AKRO) through any online brokerage.
Who are Akero Therapeutics (AKRO) competitors?
Other companies in Akero Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
What is the forecast, or price target, for Akero Therapeutics (AKRO) stock?
Akero Therapeutics has a consensus price target of $68.00.
What is the current price for Akero Therapeutics (AKRO)?
The stock price for Akero Therapeutics (NASDAQ: AKRO) is $50.58 last updated February 20, 2025 at 4:00 PM EST.
Does Akero Therapeutics (AKRO) pay a dividend?
There are no upcoming dividends for Akero Therapeutics.
When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?
Akero Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.
Is Akero Therapeutics (AKRO) going to split?
There is no upcoming split for Akero Therapeutics.
What sector and industry does Akero Therapeutics (AKRO) operate in?
Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.